Medicare Payments and Legislative Developments: A Comprehensive Overview
The House Energy and Commerce Committee is actively evaluating issues related to Medicare physician payments, with bipartisan agreement on the need for greater predictability and adequacy. Concerns were expressed about how the current payment system impacts medical workforce stability and patient access. Witnesses noted that payment instability drives physician consolidation and administrative burdens, calling for significant reforms, including backing the Strengthening Medicare for Patients and Providers Act (HR 6160) and updates to the Medicare Economic Index.
Legislative developments continue as the House Ways and Means Committee advanced healthcare bills despite proposed amendments, readying them for the House floor. Simultaneously, a session by the Senate Appropriations Committee with NIH leaders highlighted concerns over budget cuts affecting research funding. Both parties expressed worries about potential constraints on research capabilities, focusing on NIH projects in specialties like colorectal cancer and rural clinical trials.
Additionally, the House Energy and Commerce Committee has pushed forward public health legislation, addressing NIH programs and quality reporting requirements. The Centers for Medicare & Medicaid Services (CMS) has finalized the 2027 Notice of Benefit and Payment Parameters (NBPP), largely retaining initial proposals with few delayed policies. CMS also proposed a Medicaid State Directed Payment (SDP) rule aimed at aligning payment rates with Medicare guidelines.
The White House expanded its TrumpRx initiative, now featuring over 600 generic drugs. This enhancement allows consumers to compare medication prices with platforms such as Amazon Pharmacy and GoodRx, fostering better access to affordable medications. Meanwhile, the Department of Health and Human Services introduced the Audit Enforcement and Risk Oversight (AERO) initiative to improve audit compliance, employing AI to review historical audit data and ensure regulatory compliance.
In legal matters, the Supreme Court decided not to hear cases challenging the Inflation Reduction Act's Medicare drug pricing negotiations. The Department of Justice has called on lower courts to dismiss remaining challenges to support the legislation. Additionally, over 20 states have contested an Education Department rule capping student loans for specific professional degrees, seeking a court reversal due to bipartisan concerns about restricting future student funding.